Literature DB >> 18334695

Reinventing type 2 diabetes: pathogenesis, treatment, and prevention.

Roger H Unger1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18334695     DOI： 10.1001/jama.299.10.1185

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  40 in total

1.  Long Term Effects of Energy-Restricted Diets Differing in Glycemic Load on Metabolic Adaptation and Body Composition.

Authors:  Sai Krupa Das; Cheryl H Gilhooly; Julie K Golden; Anastassios G Pittas; Paul J Fuss; Gerard E Dallal; Megan A McCrory; Edward Saltzman; Susan B Roberts
Journal:  Open Nutr J       Date:  2007-04-01

Review 2.  Current insights and new perspectives on the roles of hyperglucagonemia in non-insulin-dependent type 2 diabetes.

Authors:  Xiao C Li; Jia L Zhuo
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

3.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

4.  Hoofbeats, zebras, and insights into insulin resistance.

Authors:  Robert A Hegele; Karen Reue
Journal:  J Clin Invest       Date:  2009-02       Impact factor: 14.808

5.  Noninvasive quantification of pancreatic fat in humans.

Authors:  Ildiko Lingvay; Victoria Esser; Jaime L Legendre; Angela L Price; Kristen M Wertz; Beverley Adams-Huet; Song Zhang; Roger H Unger; Lidia S Szczepaniak
Journal:  J Clin Endocrinol Metab       Date:  2009-09-22       Impact factor: 5.958

6.  Pilot study on longitudinal change in pancreatic proton density fat fraction during a weight-loss surgery program in adults with obesity.

Authors:  Yesenia Covarrubias; Kathryn J Fowler; Adrija Mamidipalli; Gavin Hamilton; Tanya Wolfson; Olof Dahlqvist Leinhard; Garth Jacobsen; Santiago Horgan; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2019-01-30       Impact factor: 4.813

7.  Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.

Authors:  Renu A Kowluru; Manish Mishra; Anjaneyulu Kowluru; Binit Kumar
Journal:  Metabolism       Date:  2016-07-30       Impact factor: 8.694

8.  Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study.

Authors:  Mohammadreza Bozorgmanesh; Farzad Hadaegh; Fereidoun Azizi
Journal:  Lipids Health Dis       Date:  2010-05-10       Impact factor: 3.876

9.  Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Naonobu Takahira; Atsuhiko Matsunaga; Naoyoshi Aoyama; Takashi Masuda; Tohru Izumi
Journal:  Cardiovasc Diabetol       Date:  2010-05-14       Impact factor: 9.951

Review 10.  A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.

Authors:  Enrique Z Fisman; Alexander Tenenbaum
Journal:  Cardiovasc Diabetol       Date:  2009-07-20       Impact factor: 9.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.